GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » Buildings And Improvements

Zahravi Pharmacutical Co (XTEH:DZAH1) Buildings And Improvements : IRR0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co Buildings And Improvements?


Zahravi Pharmacutical Co Buildings And Improvements Historical Data

The historical data trend for Zahravi Pharmacutical Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co Buildings And Improvements Chart

Zahravi Pharmacutical Co Annual Data
Trend
Buildings And Improvements

Zahravi Pharmacutical Co Semi-Annual Data
Buildings And Improvements

Zahravi Pharmacutical Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN
Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines